Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy

Status:	Completed
Conditions:	Prostate Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	8/16/2018
Start Date:	June 2012
End Date:	May 4, 2018

A Multicenter Study to Evaluate Cardiovascular Risk Factors and Receipt of Primary and Preventive Care in Prostate Cancer Patients Who Receive Definitive Radiation Therapy and Androgen Deprivation Therapy.

This study will evaluate the proportion of prostate cancer patients receiving external beam
radiation therapy (EBRT) and androgen deprivation therapy (ADT) with controlled blood sugars
(fasting glucose and hemoglobin A1c), blood pressure, and cholesterol profile (total
cholesterol, LDL, HDL, triglycerides) at baseline, 3 months, and 12 months after completing
radiation treatment. In addition, receipt of guideline-recommended cardiovascular, primary
and preventive care as well as patient-reported quality of life and satisfaction with care
among these patients will be evaluated at baseline and 12 months.

Inclusion Criteria:

- Histologically-confirmed, non-metastatic prostate cancer

- Patients who will receive external beam radiation treatment with androgen deprivation
therapy (total ADT duration > 3 months) for curative treatment, either in the
definitive or post-prostatectomy setting

- Patients who have a primary care provider

- Informed consent obtained and signed

- Ability to read and write English

- Age >= 18

- No mental incompetence which would preclude completion of questionnaires

Exclusion Criteria:

- Prior cancer, pelvic radiation treatment or chemotherapy

- Patients who do not have a primary care provider

- Prior ADT

- Mental incompetence which would preclude completion of questionnaires

- Unable to read and write English

We found this trial at

sites

MedStar Georgetown University Hospital

Washington, District of Columbia 20007

from

Washington,